CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4.
|
|
- Timothy Cannon
- 6 years ago
- Views:
Transcription
1 CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4.1 Page 1 of 11
2 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to give clear information and guidance for managing high blood glucose levels and sick days for Children/ Young people on an insulin pump under the care of the Paediatric Diabetes Service. 2. The Guidance 2.1. When you are on an insulin pump, a high blood glucose must be taken seriously as insulin pumps deliver only short or rapid-acting insulin. Without any long-acting insulin in your body, blood glucose can rise quickly if the insulin flow is accidentally interrupted and a condition called diabetic ketoacidosis (DKA) can develop. DKA is a very serious condition which must be treated immediately. Therefore if your blood glucose level is 14mmol/l or more at any stage, whether well or unwell, you must follow the flow chart in Section Sick Day Rules Illness usually causes high blood glucose levels because of the production of stress hormones and because the body becomes resistant to insulin. However diarrhoea and vomiting can lower blood glucose levels causing hypoglycaemia. Rule 1: Test don t guess! When you are unwell, test your blood glucose level at least every 2 hours. You should also check your ketone levels with each blood test. Blood ketones are most accurate, but if you have a problem with your blood ketone meter you can check urine ketones. Ketones are produced when the body breaks down fat as a source of energy. This happens in people, with or without diabetes, when they don t eat. In people with diabetes, ketones can also be produced when there is a lack of insulin e.g. if your pump is not working, or during illness, when the body becomes resistant to insulin. Rule 2: Never stop your insulin, even when you are not eating. You are likely to need etra insulin when you are unwell. In rare cases where the blood glucose levels are low (below 4mmol/l), your insulin doses may need to be reduced in this case you should phone the emergency contact number to discuss this with one of the team. Rule 3: Eat regular carbohydrate foods to prevent starvation ketones. If you aren t able to eat normal foods you can try easily digestible foods such as soup, toast, jelly and ice-cream. Or you can have frequent sugary drinks. Rule 4: Drink plenty of etra non-sugary fluids in addition to the food or sugary fluids in Rule 3. This is because high blood glucose levels, fever, diarrhoea or vomiting can cause dehydration and stop your body clearing ketones. Ketones are dangerous. They can make you feel unwell and cause diabetic ketoacidosis. Rule 5: If you have any of the following symptoms, check your blood ketones: vomiting (vomiting shouldn t be assumed to be due to a bug as ketones can cause vomiting) Page 2 of 11
3 severe abdominal (tummy) pain breathlessness, or breath smells of acetone (pear drops or nail varnish remover) drowsy signs of dehydration e.g. dry tongue, sunken eyes, cold or blue fingers and toes Blood Ketones Interpretation Action (mmol/l) Less than 0.6 Normal Give normal insulin Slightly high doses, including normal correction dose if blood glucose greater than 8-10 mmol/l High Give sick day insulin Significant risk of developing diabetic ketoacidosis dose, instead of normal correction dose, if blood glucose greater than 14 mmol/l 3.0 or above Immediate risk of diabetic ketoacidosis Phone emergency contact number 2.3. Troubleshooting Where you are directed to troubleshoot the cause of the high blood glucose level, check the following: The Infusion Set Is the tubing primed or filled with insulin? Is there air or blood in the tubing? Did you remember to fill the cannula with insulin after inserting new set? Is the tubing connected to cartridge? Is the set connected to your body? Are there any leaks? Is the cannula dislodged or kinked? Has the infusion set been in longer than 2-3 days? Is there redness at the site? Is there discomfort at the site? Is there blood on/at the site? Page 3 of 11
4 The Insulin Pump Did you forget your last bolus? (review bolus history) Have you received any recent alarms? Has your battery run down? Is your cartridge/reservoir empty? Is the date and time correct? Are your basal rates programmed correctly? Do a pump self-test after checking your pump The Insulin Is your insulin epired/inactive? Is it cloudy or clumped? How long has your insulin been at room temperature? Did you leave your insulin in a warm location? How long has the insulin been in the cartridge and tubing? Was your insulin eposed to freezing temperatures? Page 4 of 11
5 2.4. Treating High Blood Glucose Levels Insulin Pump Therapy Is the blood glucose level 14 mmol/l or above? YES Check blood ketones NO Continue normal pump doses Blood ketones 2mmol/L or higher Blood ketones between 1 and 2mmol/L Blood ketones less than 1mmol/L Give a DOUBLE correction bolus by INJECTION with an insulin pen or syringe, not via the pump: - see Section 2.5 for how to work out correction dose. Phone emergency contact number to talk through the plan on : - 8am 8pm ask for Paediatric Diabetes Nurse - 8pm 8am ask for Paediatric Registrar Give a correction bolus using the pump. Try to identify the cause of the high blood glucose level (see Troubleshooting, Section 2.3) Repeat blood glucose and ketones in two hours Give a usual correction bolus of insulin by INJECTION with an insulin pen or syringe, not via the pump: - see Section 2.5 for how to work out the correction dose Change the insulin, infusion set and cartridge. Restart your pump (do not give a correction bolus via the pump at this stage). Drink plenty of liquids that contain no calories, for eample a glass of water every thirty minutes. Try to identify the cause of the high blood glucose level (see Troubleshooting, Section 2.3). Repeat blood glucose and ketones after 1 hour: if ketones rising: repeat correction dose using an insulin pen/syringe and phone the emergency contact number if you have not already done so. if ketones falling: repeat blood glucose and ketones in 1 hour then go back to the top of the chart. Page 5 of 11
6 2.5 Conversion to Insulin Injections from Insulin Pump How to calculate the correction dose or rapid-acting insulin to be given by injection: A. If you think the pump itself is still working and there is only a problem with the cannula or tubing: - you can put your blood glucose level into the pump and it will calculate your correction dose, which you can then give by injection. B. If there is a problem with the actual pump, then you can use the Insulin Sensitivity Factor (ISF) setting on your pump for that time of day to calculate the correction dose: - If you are unable to access the settings via your actual pump, then you will need to get this information from your last pump download on Diasend. If you are not using Diasend, you should have been advised to keep a regular written record of your pump settings. - Aim for a blood glucose of 8mmol/L and round the correction dose down to the nearest half unit. - The correction dose can be calculated using the formula: (Current blood glucose level in mmol/l 8) ISF - E.g. Blood glucose currently 18mmol/l and blood ketones 0.2mmol/l. The ISF on your pump for that time of day is 3mmol/l, which means that 1 unit of insulin will bring the blood glucose down by 3mmol/l. Using the formula to aim for a blood glucose of 8mmol/l: (18 8) 3 = 3.33 units: rounded down this would be 3 units - Remember, if your ketones are greater than 2mmol/L, you should give a DOUBLE correction dose by INJECTION with a pen or syringe. If you are likely to be back on your insulin pump within the net 12 hours, you can simply give regular rapid-acting insulin (e.g. Novorapid) to cover meals and snacks using the Insulin Carbohydrate Ratio (ICR) settings on your pump. You should check your blood glucose and ketone levels at least every 2 hours and follow the guidance on page 4 if your ketones are greater than 1mmol/l or your blood glucose levels are greater than 14mmol/l. If you are not going to be back on your insulin pump within 12 hours, in addition to the rapid-acting insulin mentioned in the previous paragraph, you will also need to give long-acting insulin (e.g. Lantus or Levemir), once daily until back on your pump. The dose of long-acting insulin can be calculated by adding up your basal rates over a 24 hour period. Remember, you probably decreased your pre-pump insulin dose by 25% on starting pump therapy, so you may need etra insulin whilst on injections. If your pump is not working, please contact the pump manufacturer who will arrange to supply another pump for you if it is within warranty. Page 6 of 11
7 3. Monitoring compliance and effectiveness Element to be monitored Lead Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared Compliance with guidance Diabetes team (Dr Katie Mallam) Audit If any problems identified, or minimum 3 yearly Diabetes team and Directorate Audit and Guidelines meeting Audit lead and diabetes team Required changes to practice will be identified and actioned within a specified time frame. A lead member of the team will be identified to take each change forward where appropriate. Lessons will be shared with all the relevant stakeholders 4. Equality and Diversity 4.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendi 2. Page 7 of 11
8 Appendi 1. Governance Information Document Title Date Issued/Approved: July 2015 Clinical guideline for the management of high blood glucose levels and sick day rules on an insulin pump. Date Valid From: July 2015 Date Valid To: July 2018 Directorate / Department responsible (author/owner): Paediatric Diabetes Team led by Dr Katie Mallam Contact details: Brief summary of contents Clear guidance for management of high blood glucose levels on an insulin pump. Includes flow diagram and sick day rules. Suggested Keywords: Target Audience Eecutive Director responsible for Policy: Date revised: 09/06/2015 This document replaces (eact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Diabetes Pump High blood glucose Sick RCHT PCH CFT KCCG Managing high blood glucose level on an insulin pump. Paediatric Diabetes Team Audit and guidelines meeting Name and Post Title of additional signatories Signature of Eecutive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder {Original Copy Signed} Internet & Intranet Intranet Only Paediatrics Page 8 of 11
9 Links to key eternal standards Related Documents: Training Need Identified? no Version Control Table Date Versio n No July 2012 V1.0 Initial Issue August 2013 October 2013 July 2015 V4.0 Aug 2017 V4.1 V2.0 Minor amendments V3.0 Re format only Summary of Changes Page 2: rule 5 wording and removed urine ketones from table, Page 4 flowchart changed, Page 5 conversion to injections changed. Update of title only to include paediatric at request of adult diabetes team Changes Made by (Name and Job Title) Diabetes team- Dr. K. Mallam,Dr. S. Robertson, Anita Englan, Michelle Skewes, Pip Ali and Trish Shaw Diabetes team- Dr. K. Mallam,Dr. S. Robertson, Anita Englan, Michelle Skewes, Pip Ali and Trish Shaw Tabitha Fergus Deputy ward manger Dr Katie Mallam and the Paediatric Diabetes Team Dr Katie Mallam and Anita England All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of epiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the epress permission of the author or their Line Manager. Page 9 of 11
10 Appendi 2. Initial Equality Impact Assessment Form Name of the strategy / policy /proposal / service function to be assessed (hereafter referred to as policy) (Provide brief description): Clinical guideline for the management of high blood glucose levels on an insulin pump. Directorate and service area: Is this a new or eisting Policy? eisting Child health Name of individual completing Telephone: assessment: T. Fergus 1. Policy Aim* Who is the strategy / policy / proposal / service function aimed at? 2. Policy Objectives* Standardised practice. Clear guidance for management of high blood glucose levels on an insulin pump. Includes flow diagram and sick day rules. 3. Policy intended Outcomes* 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a) Is consultation required with the workforce, equality groups, local interest groups etc. around this policy? Evidence based, standardised care. audit Children/young people and families. no b) If yes, have these *groups been consulted? C). Please list any groups who have been consulted about this procedure. 7. The Impact Please complete the following table. Are there concerns that the policy could have differential impact on: Equality Strands: Yes No Rationale for Assessment / Eisting Evidence Age Page 10 of 11
11 Se (male, female, transgender / gender reassignment) Race / Ethnic communities /groups Disability - learning disability, physical disability, sensory impairment and mental health problems Religion / other beliefs Marriage and civil partnership Pregnancy and maternity Seual Orientation, Biseual, Gay, heteroseual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked Yes in any column above and No consultation or evidence of there being consultation- this ecludes any policies which have been identified as not requiring consultation. or Major service redesign or development 8. Please indicate if a full equality analysis is recommended. Yes No 9. If you are not recommending a Full Impact assessment please eplain why. No negative aspects Signature of policy developer / lead manager / director T.fergus Date of completion and submission October 2013 Names and signatures of members carrying out the Screening Assessment Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD A summary of the results will be published on the Trust s web site. Signed T.Fergus Date 30/10/13 Page 11 of 11
Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018
Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0 March 2018 Page 1 of 8 Summary flow chart for monitoring of blood glucose if >11mmol/L For Adults
More informationHYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance
HYPOSPADIAS NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all staff managing the initial care of infants born with hypospadias. It includes assessment and
More informationClinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol
Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol 1. Aim/Purpose of this Guideline 1.1. To Provide safe and efficient administration of Opioids in Recovery.
More informationHypoglycaemia in Adults with Diabetes Clinical Guideline V5.0. March 2018
March 2018 Page 1 of 11 Adult with Diabetes and blood glucose < 4 mmol/l Treatment as per Guideline: Nursing / Clinical Staff Patient reviewed as per guideline guidance notes: Nursing / Clinical Staff
More informationMANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE
MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. To provide guidance on the assessment and management of infants with hypotension. All involved will benefit from
More informationCLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1.
CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1. Patient requires nebulised Pentamidine Ensure equipment listed is available Ensure HEPA filtered room in Haematology Clinic
More informationCLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS
CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of gallstones pathology in adults. It has been benchmarked against
More informationDIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0
DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline This guideline is relevant to all medical and nursing staff caring for children with Pyloric
More informationCLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary.
CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary. Yes Is patient prescribed ifosfamide or cyclophosphamide >1g/m 2? Chemotherapy prescription on Aria should
More informationSALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department
More information28 th September Author Jeremy Gilbert Bariatric Nurse Specialist
POLICY FOR SELF ADMINISTRATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE BY COMPETENT PATIENTS COMING IN FOR METABOLIC AND OBESITY SURGERY (BARIATRIC SURGERY) TO PENDENNIS WARD 28 th September 2014 Author
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary.
CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary. Page 1 of 12 Recurrent LGD at any point- discuss at MDT And consider RFA Patients with LGD should have a repeat endoscopy in 6 months.
More informationSchool Hearing Screening Policy
School Hearing Screening Policy V2.1 1st August 2017 Page 1 of 13 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...
More informationFasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0
Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation November 2018 Summary. Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia
More informationMETABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0
METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0 Page 1 of 10 1. Aim/Purpose of this Guideline To provide guidance on the prevention of metabolic bone disease in the neonate. All
More information1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate.
SHARED CARE GUIDELINE FOR ACAMPROSATE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of
More informationSHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN
SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the
More informationMANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES
MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES 1. Aim/Purpose of this Guideline All clinical staff working in the Division of women,
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationStart. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.
CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOPHOSPHATAEMIA IN ADULTS Summary. Key: General Notes GP/SWASFT ED/MAU/SRU/Acute GP/Amb-Care In-patient wards Start What is the serum concentration? Mild Hypophosphataemia
More informationCLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0
CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0 Page 1 of 11 1. Aim/Purpose of this Guideline 1.1. Tuberculosis is a notifiable disease in the UK and although incidence is low it remains a Public
More informationCLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline 1.1. This guideline contains recommendations about general principles for managing intravenous (IV)
More informationCLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)
CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological
More informationGESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE
GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE V 1.5 2017 Screening - Clinical Guideline Page 1 of
More informationPRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0
PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0 Page 1 of 8 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical and nursing staff caring for a child with Preseptal
More informationCLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline Guideline for children with a Patient Controlled Analgesia
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0
CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAIS IN INFANTS AND CHILDREN UNDER SITEEN YEARS OF AGE V3.0 Page 1 of 16 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide
More informationManaging your Diabetes when you are Sick. Type 1 Diabetes Insulin Pump
Managing your Diabetes when you are Sick Type 1 Diabetes Insulin Pump Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified health-care
More informationThe Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline V5.0 December 2018
The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline December 2018 Summary GP suspects diabetes Under 16 years or still in School Year 11 NO Refer Adults YES Section
More informationCLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS
CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of acute cholecystitis in adults. It has been benchmarked against
More informationPatient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018
Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018 Page 1 of 12 1. Aim/Purpose of this Guideline Guideline for children with a Patient Controlled
More informationSHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline. 2. The Guidance
SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of modafinil.
More informationSHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline
SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy
More informationClinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall
Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall Page 1 of 15 Summary Patient clinically assessed and reviewed by a Consultant Cardiologist, Cardiology
More informationGuideline on Sick day rules for children and young people with diabetes on insulin
Guideline on Sick day rules for children and young people with diabetes on insulin META DATA Title: Guidelines on Sick day rules for children and young people with Diabetes taking insulin Version: 1.0
More informationCLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide guidance on caring for children who are receiving epidural
More informationCaptopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0
Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0 November 2018 Summary Prescribing, monitoring and administration of Captopril and Enalapril FOR STAFF PATIENTS Medical and Nursing
More informationPelvic Inflammatory Disease Clinical Guideline V1.0 February 2019
Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019 Summary This guideline will provide evidence based guidance on the management of Pelvic Inflammatory Disease A low threshold for empirical
More informationStaying safe on an insulin pump
Staying safe on an insulin pump Exceptional healthcare, personally delivered Insulin pump therapy is a safe and effective way of treating diabetes. However due to the way the insulin is delivered, problems
More informationCLINICAL PROCEDURE FOR THE SAFE REMOVAL OF FEMORAL ARTERIAL SHEATHS USING A DIGITAL APPROACH 1. Aim/Purpose of this Guideline
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationClinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4
Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4 Page 1 of 27 Abbreviation Meaning PDSN DKA BG SC IV RCHT HDU PEWS Paediatric
More informationSick day rules. associated with insulin dependent diabetes. Information for children and young people. Women and Children Paediatrics
Sick day rules associated with insulin dependent diabetes Information for children and young people Women and Children Paediatrics This information leaflet is for children and young people. If a parent
More informationContinuous Subcutaneous Insulin Infusion (CSII) pump therapy
Page 1 of 14 Continuous Subcutaneous Insulin Infusion (CSII) pump therapy Introduction This booklet has been compiled by the Insulin Pump Therapy Team to standardise the information given to patients on
More informationTYPE 1 DIABETES on a pump
TYPE 1 DIABETES on a pump Advice from the Cedar Centre Patient information leaflet How do I look after myself if I am unwell and have TYPE 1 DIABETES? We all get ill occasionally with the flu or a tummy
More informationProcedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0
Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0 11 October 2017 Table of Contents 1. Introduction.. 3 2. Purpose of this Policy/Procedure. 3 3. Scope
More informationTYPE 1 DIABETES: WHAT TO DO WHEN YOU ARE ILL
LIFESTYLE TYPE 1 DIABETES: WHAT TO DO WHEN YOU ARE ILL kk WHY IS THIS LEAFLET FOR YOU? Everyone has days when they are not well. If you have diabetes, being unwell can affect your blood glucose control
More informationSuspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationDIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4
DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4 1 1. Aim/Purpose of this Guideline To provide guidance to Midwives, Obstetricians and the Joint Obstetric/Diabetes
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0
CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all nursing
More informationAROMATHERAPY - CLINICAL GUIDELINE FOR MIDWIVES. January 2018
AROMATHERAPY - CLINICAL GUIDELINE FOR MIDWIVES V2 January 2018 1. Aim/Purpose of this Guideline 1.1. Aromatherapy is the use of essential oils, which can be administered by topical application via massage,
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary. Start. End. Key: Na + below normal range ( mmol/L) Symptomatic?
CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary Key: General tes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Na + below normal range (135 145mmol/L) Refer to endocrinology
More informationExecutive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)
Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young
More informationPrevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018
Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018 1. Aim/Purpose of this Guideline This guideline applies to all medical and nursing staff
More informationCLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY
This applies to adult patients only CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Yes Patient already taking phenytoin?
More informationManaging your Diabetes when you are Sick. Type 1 Diabetes
Managing your Diabetes when you are Sick Type 1 Diabetes Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified health-care provider.
More informationDiabetes, Ketone testing in Type 1 Diabetes
CLINICAL GUIDELINE Diabetes, Ketone testing in Type 1 Diabetes A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised
More informationMy Sick Day Plan for Type 1 Diabetes on Multiple Daily Injections (MDI)
My Sick Day Plan for Type 1 Diabetes on Multiple Daily Injections (MDI) When you are sick, your blood sugar levels may be harder to keep under control. Your blood sugar may go too high or too low. Use
More informationOsteoblasts (cells which form new bone) Osteoclasts (cells which break down old bone)
Clinical guideline for the administration of Bisphosphonates and other drugs affecting bone metabolism in Haematology and Oncology patients 1. Aim/Purpose of this Guideline 1.1. To provide education to
More information2016 Diabetes Management Plan
Early childhood education and care setting 2016 Diabetes Management Plan Insulin pump therapy [to be used in conjunction with Action Plan] Name of child: Date of birth: Name of centre: Age : This plan
More informationNorthumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service
Northumbria Healthcare NHS Foundation Trust Sick Day Rules for People with Diabetes Issued by the Diabetes Service www.northumbria.nhs.uk Background: How illness may affect your diabetes 3 What to do for
More informationTYPE 1 DIABETES on 4 or more injections per day. Advice from the Cedar Centre. x 4 or more. Patient information leaflet
TYPE 1 DIABETES on 4 or more injections per day Advice from the Cedar Centre x 4 or more Patient information leaflet How do I look after myself if I am unwell and have DIABETES? Anyone can get flu or a
More informationUniversity College Hospital. Blood glucose and HbA 1 c targets
University College Hospital Blood glucose and HbA 1 c targets Children & Young People s Diabetes Service The diabetes team at UCLH aims to help every child and young person with Type 1 Diabetes to safely
More informationTitle Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline
Document Control Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline Author Directorate Version Author s job title Consultant Paediatrician Department
More informationssociation of Children s Diabetes Clinicians Clinicians Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients
ssociation of Children s Diabetes Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients 1 ssociation of Children s Diabetes Contents Chapter Page no. STEP 1...3 Getting
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0
CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0 Clinical Guideline Template Page 1 of 13 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all nursing
More informationMUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0
MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0 Page 1 of 10 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all medical and nursing
More informationDIABETES MANAGEMENT PLAN 2017
EARLY CHILDHOOD EDUCATION AND CARE SETTING Insulin pump therapy Use in conjunction with Action Plan DIABETES MANAGEMENT PLAN 2017 Name of child: Name of centre: of birth: Age: This plan should be reviewed
More informationCASE 8 Unwell insulin-dependent diabetic
50 CASE 8 Unwell insulin-dependent diabetic INFORMATION FOR THE DOCTOR This is a telephone consultation. Name Michael Ede Age 29 Past medical history Type 1 diabetes 2 years ago Patello-femoral knee joint
More informationPump Failure Guidelines
Pump Failure Guidelines Planning Ahead All technology, including pumps, can fail occasionally, even within their warranty period. It is important to be able to independently initiate injection treatment
More informationSick Day Guidelines and Ketone Testing
Sick Day Guidelines Sick Day Guidelines and Ketone Testing 6 Steps for Sick Days (All Patients) 1. Prevention: Get influenza vaccination yearly and pnuemococcal vaccination if >65 years old. Eat a healthy
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff
More informationMy sick day plan for Type 1 Diabetes
My sick day plan for Type 1 Diabetes When you get sick, your blood sugar levels may be harder to keep under control. Your blood sugars may go too high or too low. Be prepared before you get sick. This
More informationDIABETES MANAGEMENT PLAN 2017
SCHOOL SETTING Insulin pump therapy Use in conjunction with Action Plan DIABETES MANAGEMENT PLAN 2017 Name of student: Name of school: Date of birth: Grade/Year: Insulin pump model: This plan should be
More informationCLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0
CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0 Clinical Guideline Template Page 1 of 18 Page 1 of 13 1. Aim/Purpose of this Guideline 1.1. This guideline applies
More informationVICTORIA INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan
VICTORIA INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. Student s Name: of Birth: of Diabetes
More informationDiabetes Medical Management Plan
MADISON CONSOLIDATED SCHOOLS Diabetes Medical Management Plan Date of Plan: Effective Dates : The student s personal health care team and parents/guardian should complete this plan. It should be reviewed
More informationDiabetes Medical Management Plan
of Plan: School year: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and
More informationAuthorization for MAT Diabetes Certified Staff to Administer Insulin and/or Glucagon
Medication Administration Training for Child Day Programs Handout B.1 Authorization for MAT Diabetes Certified Staff to Administer Insulin and/or Glucagon Child s Name: Child s Date of Birth: Child Day
More informationSHARED CARE GUIDELINE FOR TREATMENT OF DEMENTIA 1. Aim/Purpose of this Guideline
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More information2016 Diabetes Management Plan for school Insulin pump therapy [to be used in conjunction with Action Plan]
2016 Diabetes Management Plan for school Insulin pump therapy [to be used in conjunction with Action Plan] Name of student: Date of birth: Name of school: Grade/Year : Insulin pump model: This plan should
More informationTechnology for Diabetes: 101 Basic Rules of the Road. Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE
Technology for Diabetes: 101 Basic Rules of the Road Karen Hamon RN, BSN, CDE Stephen Stone MD, FAAP Neil H. White, MD, CDE Quick Pump Facts! o Constant insulin supply o Pager-sized mini-computer worn
More informationIndividual healthcare plan for Type 1 diabetes. for children/young people with diabetes in schools and Early Years settings
Individual healthcare plan for Type 1 diabetes for children/young people with diabetes in schools and Early Years settings Individual healthcare plan for Type 1 diabetes for children/young people with
More informationDiabetes Medical Management Plan
SCHOOL DISTRICT OF LEE COUNTY HEALTH SERVICES Print Form Date of Plan Diabetes Medical Management Plan This plan should be completed by the student's personal health care team and parents/guardian. It
More informationWhat do you need to know before you go home?
What do you need to know before you go home? What is Insulin Types of Insulin Injection Sites How to Inject Insulin Correctly Low Blood Sugar and Treatment Sick Day Management After leaving the Hospital:
More informationCLINICAL GUIDELINE FOR ANTIEMETIC USE IN PAEDIATRIC ONCOLOGY 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR ANTIEMETIC USE IN PAEDIATRIC ONCOLOGY 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical and nursing staff working with paediatric oncology patients. 2. The
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with relevant school staff
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff
More informationHomeroom Teacher: Mother/Guardian: Address: Telephone: Home Work. Address: Father/Guardian: Address: Telephone: Home Work Cell: Address:
Community Unit School District No. 1 Diabetes Care Plan 6:120-AP4, E1 This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed
More informationDiabetes Medical Management Plan
Diabetes Medical Management Plan This plan should be completed by the student's personal health care team and parents/guardian. It should be reviewed with relevant school staff and copies should be kept
More informationDiabetes Medical Management Plan
Diabetes Medical Management Plan 1 School District: School: School Year: Grade: Student Name: DOB: Provider Name: Phone #: Fax #: Blood Glucose Monitoring at School Blood Glucose Target Range: - mg/dl
More informationTraining booklet for understanding. Hypoglycaemia - LOW Blood glucose levels Hyperglycaemia - HIGH Blood glucose levels
Integrated Community Diabetes Services The Poynt, Units 2-3 Poynters Road Luton, LU4 0LA Tel: 0333 405 3128 Training booklet for understanding Hypoglycaemia - LOW Blood glucose levels Hyperglycaemia -
More informationInternational School Bangkok Diabetes Management Plan 2018/19
International School Bangkok Diabetes Management Plan 2018/19 Student Family Name: Given Names: Date of Birth (dd/mm/yyyy): Grade at ISB (2018/19): Date of Plan (dd/mm/yyyy): Mother s Name: Phone: Father
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) Page 1 of 7, DMMP This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with
More informationDiabetes Medical Management Plan
Date of Plan: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and copies
More informationLOW BLOOD GLUCOSE (Hypoglycemia)
Section Four DAILY CRISES In this section, you will learn about: Low blood glucose High blood glucose Diabetic Ketoacidosis Hyperosmolar Hyperglycemic Nonketotic Syndrome LOW BLOOD GLUCOSE (Hypoglycemia)
More informationDIABETES MANAGEMENT PLAN 2019
SCHOOL SETTING Insulin pump therapy Use in conjunction with Action Plan This plan has been adapted from the original work of Diabetes Victoria, Monash Children s Hospital and the Royal Children s Hospital,
More informationPump Basics for the School Nurse. Children's Endocrinology Center of Dallas
Pump Basics for the School Nurse Children's Endocrinology Center of Dallas Pump Basics Covers: A general overview of the insulin pump Refer to the manufacturer s website for the specific features of each
More informationNational Diabetes Inpatient Audit (NaDIA) 2016
National Diabetes Inpatient Audit (NaDIA) 2016 DIABETES A summary report for people with diabetes and anyone interested in the quality of care for people with diabetes when they stay in hospital. Based
More informationFeeling sick? What to do. Information for people with Type 1 Diabetes
Feeling sick? What to do Information for people with Type 1 Diabetes Diabetes and sick days A minor illness can result in a major rise in blood glucose levels Common illnesses such as tonsillitis, ear,
More information